• home
  • contact us
  • careers
  • employee login
  • about YM
    • History
    • Business Development
      • In-Licensing
    • Management Team
    • Board of Directors
    • Professional Affiliations
  • products
    • CYT387
      • Publications
      • Clinical Trials
    • Nimotuzumab
      • Publications
      • Safety Profile
      • Clinical Trials
      • Consortium
      • Licensee Links
    • CYT997
      • Publications
      • Clinical Trials
    • Clinical Trials
    • Request Medical Info
  • investors
    • Financial Reports
    • Regulatory Filings
    • Stock Information
    • Press Releases
    • Calendar of Events
    • Presentations
    • Corporate Governance
    • Analyst Coverage
    • Investor Contacts
    • Email Sign-up
  • patients
    • CYT387
    • Nimotuzumab
      • Patients - Canada
      • Patients - USA
      • Patients - Worldwide
    • CYT997
  • physicians
    • CYT387
    • Nimotuzumab
    • CYT997
  • contact
    • Bus. Dev. Contacts
    • Investor Contacts
  • Business Model
    • Business Development
  • CYT387
    • CYT387 Overview
    • Publications
    • Clinical Trials
  • Nimotuzumab
    • Nimotuzumab Overview
    • Publications
    • Safety Profile
    • Clinical Trials
    • Consortium
  • CYT997
    • CYT997 Overview
    • Publications
    • Clinical Trials
Investors
Financial Reports
Regulatory Filings
Stock Information
Press Releases
Calendar of Events
Presentations
Corporate Governance
Analyst Coverage
Investor Contacts
Email Sign-up

Regulatory Filings

View document (PDF)

Supplemental Return Card


Annual Information Forms (AIFs)

View document (PDF)

Year Ended June 30, 2011

View document (PDF)

Year Ended June 30, 2010

View document (PDF)

Year Ended June 30, 2009

View document (PDF)

Year Ended June 30, 2008

View document (PDF)

Year Ended June 30, 2007

View document (PDF)

Year Ended June 30, 2006

View document (PDF)

Year Ended June 30, 2005 Amended
View document (PDF) Year Ended June 30, 2004
View document (PDF) Year Ended June 30, 2003
View document (PDF) Year Ended June 30, 2002
View document (PDF) Year Ended June 31, 2001


Management Proxy / Information Circulars

View document (PDF)

October 28, 2011

View document (PDF)

October 25, 2010

View document (PDF)

October 9, 2009

View document (PDF)

October 21, 2008

View document (PDF)

October 23, 2007

View document (PDF)

October 10, 2006

View document (PDF)

September 28, 2005
View document (PDF) November 17, 2004
View document (PDF) November 5, 2003
View document (PDF) November 6, 2002


Prospectus Documents

View document (PDF)

July 14, 2011 - Short Form Prospectus

View document (PDF)

March 16, 2011 - Prospectus Supplement Amendment No.1

View document (PDF)

January 14, 2011 - Prospectus Supplement

View document (PDF)

January 7, 2011 - Amended and Restated Prospectus Supplement

View document (PDF)

December 14, 2010 - Prospectus Supplement

View document (PDF)

November 30, 2010 - Amended and Restated Short Form Prospectus

View document (PDF)

June 3, 2010 - Prospectus Supplement

View document (PDF)

April 26, 2010 - Prospectus Supplement

View document (PDF)

March 5, 2010 - Prospectus Supplement

View document (PDF)

September 16, 2009 - Short Form Prospectus

View document (PDF)

February 3, 2006 - Short Form Prospectus

View document (PDF)

September 23, 2004 - Short Form Prospectus

View document (PDF)

February 13, 2004 - Long Form Prospectus
View document (PDF) May 31, 2002 - Long Form Prospectus
View document (PDF) May 31, 2002 - Long Form Prospectus (French)
View document (PDF) May 31, 2002 - UK Wrap for Final Prospectus


View other YM BioSciences public documents at www.sedar.com.

© 2009 YM BioSciences Inc.       privacy policy       legal disclaimer       home
events
news
presentations
financial reports
email sign-up